昭和大学藤が丘病院における抗ＭＲＳＡ薬の適正使用へ向けたＩＣＴの取り組み
スポンサーリンク
概要
- 論文の詳細を見る
The infection control team at Showa University Fujigaoka Hospital placed a formulary restriction on physicians'use of anti-methicillin resistant Staphylococcus aureus (MRSA) agents (vancomycin,arbekacin and teicoplanin) in January 2004.To evaluate the effect of this restriction,we investigated the changes in numbers of vials of anti-MRSA agents used between 1 year before and 1 year after the restriction was implemented,and in the numbers of new MRSA-positive inpatients (newly registered inpatients with MRSA infection or contamination).There was a significant decrease in monthly vial consumption for intravenous (iv) and oral vancomycins.This was accompanied by a 66% decrease in the cost of vancomycins used.However,there was no increase in the number of newly registered MRSA-positive inpatients over this period.There was also no significant change in monthly vial consumption for the newer anti-MRSA agents,arbekacin and teicoplanin,which was because the number of prescriptions of these drugs was much smaller than that for vancomycins.By hospital department,there was a remarkable decrease in iv and oral vancomycin usage in Gastroenterology and in the use of iv vancomycins in Chest Surgery.However,there was no significant decrease in newly registered MRSA-positive patients in these 2 departments.These findings suggest that such a formulary restriction contributes to ensuring the proper usage of anti-MRSA agents for inpatients with MRSA infections as well as to reducing medical costs.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)